Serum HCG measured in the peri-implantation period predicts IVF cycle outcomes Bruce S. Shapiro, Said T. Daneshmand, Humberto Restrepo, Forest C. Garner Reproductive BioMedicine Online Volume 25, Issue 3, Pages 248-253 (September 2012) DOI: 10.1016/j.rbmo.2012.05.015 Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions
Figure 1 Ongoing pregnancy per transfer versus serum human chorionic gonadotrophin (HCG) measured 5days after blastocyst transfer. Reproductive BioMedicine Online 2012 25, 248-253DOI: (10.1016/j.rbmo.2012.05.015) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions
Figure 2 Rates of multiple and singleton pregnancy versus serum human chorionic gonadotrophin (HCG) measured 5days after blastocyst transfer. Rates were calculated among clinical pregnancies. Reproductive BioMedicine Online 2012 25, 248-253DOI: (10.1016/j.rbmo.2012.05.015) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions
Figure 3 Rates of ectopic pregnancy, biochemical pregnancy loss and spontaneous abortion (SAB) at less than 10weeks’ gestation versus serum human chorionic gonadotrophin (HCG) measured 5days after blastocyst transfer. The ectopic pregnancy and biochemical pregnancy rates are per pregnancy. The SAB rate is per intrauterine pregnancy. Reproductive BioMedicine Online 2012 25, 248-253DOI: (10.1016/j.rbmo.2012.05.015) Copyright © 2012 Reproductive Healthcare Ltd. Terms and Conditions